Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Prenatally diagnosed periventricular nodular heterotopia: Further delineation of the imaging phenotype and outcome.

Deloison B, Sonigo P, Millischer-Bellaiche AE, Quibel T, Cavallin M, Benoist G, Quelin C, Jouk PS, Lev D, Alison M, Baumann C, Beldjord C, Razavi F, Bessières B, Boddaert N, Ville Y, Salomon LJ, Bahi-Buisson N.

Eur J Med Genet. 2018 Nov 1. pii: S1769-7212(17)30771-1. doi: 10.1016/j.ejmg.2018.10.015. [Epub ahead of print]

PMID:
30391507
2.

Further refinement of COL4A1 and COL4A2 related cortical malformations.

Cavallin M, Mine M, Philbert M, Boddaert N, Lepage JM, Coste T, Lopez-Gonzalez V, Sanchez-Soler MJ, Ballesta-Martínez MJ, Remerand G, Pasquier L, Guët A, Chelly J, Lascelles K, Prieto-Morin C, Kossorotoff M, Tournier Lasserve E, Bahi-Buisson N.

Eur J Med Genet. 2018 Oct 11. pii: S1769-7212(17)30844-3. doi: 10.1016/j.ejmg.2018.10.004. [Epub ahead of print]

PMID:
30315939
3.

Mutations in TBR1 gene leads to cortical malformations and intellectual disability.

Vegas N, Cavallin M, Kleefstra T, de Boer L, Philbert M, Maillard C, Boddaert N, Munnich A, Hubert L, Bery A, Besmond C, Bahi-Buisson N.

Eur J Med Genet. 2018 Sep 27. pii: S1769-7212(17)30791-7. doi: 10.1016/j.ejmg.2018.09.012. [Epub ahead of print]

PMID:
30268909
4.

Recurrent RTTN mutation leading to severe microcephaly, polymicrogyria and growth restriction.

Cavallin M, Bery A, Maillard C, Salomon LJ, Bole C, Reilly ML, Nitschké P, Boddaert N, Bahi-Buisson N.

Eur J Med Genet. 2018 Aug 16. pii: S1769-7212(17)30720-6. doi: 10.1016/j.ejmg.2018.08.001. [Epub ahead of print]

PMID:
30121372
5.

The hypothalamic-pituitary-testicular axis and the testicular function are modulated after silver nanoparticle exposure.

Cavallin MD, Wilk R, Oliveira IM, Cardoso NCS, Khalil NM, Oliveira CA, Romano MA, Romano RM.

Toxicol Res (Camb). 2017 Nov 23;7(1):102-116. doi: 10.1039/c7tx00236j. eCollection 2018 Jan 1.

PMID:
30090567
6.

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M; ANSWER Study Investigators.

Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1. Erratum in: Lancet. 2018 Aug 4;392(10145):386.

PMID:
29861076
7.

TLE1, a key player in neurogenesis, a new candidate gene for autosomal recessive postnatal microcephaly.

Cavallin M, Maillard C, Hully M, Philbert M, Boddaert N, Reilly ML, Nitschké P, Bery A, Bahi-Buisson N.

Eur J Med Genet. 2018 May 25. pii: S1769-7212(17)30773-5. doi: 10.1016/j.ejmg.2018.05.002. [Epub ahead of print]

PMID:
29758293
8.

WDR81 mutations cause extreme microcephaly and impair mitotic progression in human fibroblasts and Drosophila neural stem cells.

Cavallin M, Rujano MA, Bednarek N, Medina-Cano D, Bernabe Gelot A, Drunat S, Maillard C, Garfa-Traore M, Bole C, Nitschké P, Beneteau C, Besnard T, Cogné B, Eveillard M, Kuster A, Poirier K, Verloes A, Martinovic J, Bidat L, Rio M, Lyonnet S, Reilly ML, Boddaert N, Jenneson-Liver M, Motte J, Doco-Fenzy M, Chelly J, Attie-Bitach T, Simons M, Cantagrel V, Passemard S, Baffet A, Thomas S, Bahi-Buisson N.

Brain. 2017 Oct 1;140(10):2597-2609. doi: 10.1093/brain/awx218.

PMID:
28969387
9.

Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis Forum.

der Strate BV, Longdin R, Geerlings M, Bachmayer N, Cavallin M, Litwin V, Patel M, Passe-Coutrin W, Schoelch C, Companjen A, Fjording MS.

Bioanalysis. 2017 Aug;9(16):1253-1264. doi: 10.4155/bio-2017-0093. Epub 2017 Aug 2.

10.

Delayed onset of puberty in male offspring from bisphenol A-treated dams is followed by the modulation of gene expression in the hypothalamic-pituitary-testis axis in adulthood.

Oliveira IM, Romano RM, de Campos P, Cavallin MD, Oliveira CA, Romano MA.

Reprod Fertil Dev. 2017 Nov;29(12):2496-2505. doi: 10.1071/RD17107.

PMID:
28641706
11.

ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.

Tiribelli M, Geromin A, Cavallin M, Di Giusto S, Simeone E, Fanin R, Damiani D.

Eur J Haematol. 2017 Sep;99(3):269-274. doi: 10.1111/ejh.12915. Epub 2017 Jul 20.

PMID:
28618016
12.

High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.

Tiribelli M, Raspadori D, Geromin A, Cavallin M, Sirianni S, Simeone E, Bocchia M, Fanin R, Damiani D.

Leuk Res. 2017 Jul;58:31-38. doi: 10.1016/j.leukres.2017.04.001. Epub 2017 Apr 4.

PMID:
28407515
13.

Neuropathological Hallmarks of Brain Malformations in Extreme Phenotypes Related to DYNC1H1 Mutations.

Laquerriere A, Maillard C, Cavallin M, Chapon F, Marguet F, Molin A, Sigaudy S, Blouet M, Benoist G, Fernandez C, Poirier K, Chelly J, Thomas S, Bahi-Buisson N.

J Neuropathol Exp Neurol. 2017 Mar 1;76(3):195-205. doi: 10.1093/jnen/nlw124.

PMID:
28395088
14.

Prenatal and postnatal presentations of corpus callosum agenesis with polymicrogyria caused by EGP5 mutation.

Maillard C, Cavallin M, Piquand K, Philbert M, Bault JP, Millischer AE, Moshous D, Rio M, Gitiaux C, Boddaert N, Masson C, Thomas S, Bahi-Buisson N.

Am J Med Genet A. 2017 Mar;173(3):706-711. doi: 10.1002/ajmg.a.38061. Epub 2017 Feb 7.

PMID:
28168853
15.

A novel recurrent LIS1 splice site mutation in classic lissencephaly.

Philbert M, Maillard C, Cavallin M, Goldenberg A, Masson C, Boddaert N, El Morjani A, Steffann J, Chelly J, Gerard X, Bahi-Buisson N.

Am J Med Genet A. 2017 Feb;173(2):561-564. doi: 10.1002/ajmg.a.38041. Epub 2016 Nov 27. No abstract available.

PMID:
27891766
16.

Recurrent KIF2A mutations are responsible for classic lissencephaly.

Cavallin M, Bijlsma EK, El Morjani A, Moutton S, Peeters EA, Maillard C, Pedespan JM, Guerrot AM, Drouin-Garaud V, Coubes C, Genevieve D, Bole-Feysot C, Fourrage C, Steffann J, Bahi-Buisson N.

Neurogenetics. 2017 Apr;18(2):73-79. doi: 10.1007/s10048-016-0499-8. Epub 2016 Oct 17.

PMID:
27747449
17.

Tubulinopathies Overview.

Bahi-Buisson N, Cavallin M.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2016 Mar 24.

18.

De novo TUBB2B mutation causes fetal akinesia deformation sequence with microlissencephaly: An unusual presentation of tubulinopathy.

Laquerriere A, Gonzales M, Saillour Y, Cavallin M, Joyē N, Quēlin C, Bidat L, Dommergues M, Plessis G, Encha-Razavi F, Chelly J, Bahi-Buisson N, Poirier K.

Eur J Med Genet. 2016 Apr;59(4):249-56. doi: 10.1016/j.ejmg.2015.12.007. Epub 2015 Dec 28.

19.

Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.

Cavallin M, Piano S, Romano A, Fasolato S, Frigo AC, Benetti G, Gola E, Morando F, Stanco M, Rosi S, Sticca A, Cillo U, Angeli P.

Hepatology. 2016 Mar;63(3):983-92. doi: 10.1002/hep.28396. Epub 2016 Feb 3.

PMID:
26659927
20.

Hepatic decompensation in the absence of obvious precipitants: the potential role of cytomegalovirus infection/reactivation.

Rosi S, Poretto V, Cavallin M, Angeli P, Amodio P, Sattin A, Montagnese S.

BMJ Open Gastroenterol. 2015 Aug 13;2(1):e000050. doi: 10.1136/bmjgast-2015-000050. eCollection 2015.

21.

Reply.

Cavallin M, Piano S, Angeli P.

Hepatology. 2016 Jul;64(1):318. doi: 10.1002/hep.28324. Epub 2015 Dec 22. No abstract available.

PMID:
26524375
22.

Recurrent KIF5C mutation leading to frontal pachygyria without microcephaly.

Cavallin M, Hubert L, Cantagrel V, Munnich A, Boddaert N, Vincent-Delorme C, Cuvellier JC, Masson C, Besmond C, Bahi-Buisson N.

Neurogenetics. 2016 Jan;17(1):79-82. doi: 10.1007/s10048-015-0459-8. Epub 2015 Sep 19. No abstract available.

PMID:
26384676
23.

Rare ACTG1 variants in fetal microlissencephaly.

Poirier K, Martinovic J, Laquerrière A, Cavallin M, Fallet-Bianco C, Desguerre I, Valence S, Grande-Goburghun J, Francannet C, Deleuze JF, Boland A, Chelly J, Bahi-Buisson N.

Eur J Med Genet. 2015 Aug;58(8):416-8. doi: 10.1016/j.ejmg.2015.06.006. Epub 2015 Jul 16.

PMID:
26188271
24.

The Treatment of Hepatorenal Syndrome.

Cavallin M, Fasolato S, Marenco S, Piano S, Tonon M, Angeli P.

Dig Dis. 2015;33(4):548-54. doi: 10.1159/000375346. Epub 2015 Jul 6. Review.

PMID:
26159272
25.

The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.

Piano S, Fasolato S, Salinas F, Romano A, Tonon M, Morando F, Cavallin M, Gola E, Sticca A, Loregian A, Palù G, Zanus G, Senzolo M, Burra P, Cillo U, Angeli P.

Hepatology. 2016 Apr;63(4):1299-309. doi: 10.1002/hep.27941. Epub 2015 Aug 4.

PMID:
26084406
26.

ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.

Damiani D, Tiribelli M, Geromin A, Michelutti A, Cavallin M, Sperotto A, Fanin R.

Am J Hematol. 2015 Sep;90(9):784-9. doi: 10.1002/ajh.24084. Epub 2015 Jul 22.

27.

New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?

Rosi S, Piano S, Frigo AC, Morando F, Fasolato S, Cavallin M, Gola E, Romano A, Montagnese S, Sticca A, Gatta A, Angeli P.

Liver Int. 2015 Sep;35(9):2108-14. doi: 10.1111/liv.12852. Epub 2015 May 7.

PMID:
25900355
28.

First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014.

Basu B, Dean E, Puglisi M, Greystoke A, Ong M, Burke W, Cavallin M, Bigley G, Womack C, Harrington EA, Green S, Oelmann E, de Bono JS, Ranson M, Banerji U.

Clin Cancer Res. 2015 Aug 1;21(15):3412-9. doi: 10.1158/1078-0432.CCR-14-2422. Epub 2015 Mar 24.

29.

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.

Cavallin M, Kamath PS, Merli M, Fasolato S, Toniutto P, Salerno F, Bernardi M, Romanelli RG, Colletta C, Salinas F, Di Giacomo A, Ridola L, Fornasiere E, Caraceni P, Morando F, Piano S, Gatta A, Angeli P; Italian Association for the Study of the Liver Study Group on Hepatorenal Syndrome.

Hepatology. 2015 Aug;62(2):567-74. doi: 10.1002/hep.27709. Epub 2015 Feb 13.

PMID:
25644760
30.

Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be".

Piano S, Tonon M, Cavallin M, Morando F, Romano A, Gola E, Fasolato S, Angeli P.

J Hepatol. 2015 Mar;62(3):744-6. doi: 10.1016/j.jhep.2014.12.001. Epub 2014 Dec 5. No abstract available.

31.

Portable device technology in organ donation: new "app" for procurement coordinators.

Cavallin M, Bertini P, Lopane P, Guarracino F.

Transplant Proc. 2014 Sep;46(7):2192-4. doi: 10.1016/j.transproceed.2014.07.033.

PMID:
25242748
32.

Mutations in B9D1 and MKS1 cause mild Joubert syndrome: expanding the genetic overlap with the lethal ciliopathy Meckel syndrome.

Romani M, Micalizzi A, Kraoua I, Dotti MT, Cavallin M, Sztriha L, Ruta R, Mancini F, Mazza T, Castellana S, Hanene B, Carluccio MA, Darra F, Máté A, Zimmermann A, Gouider-Khouja N, Valente EM.

Orphanet J Rare Dis. 2014 May 5;9:72. doi: 10.1186/1750-1172-9-72.

33.

Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study.

Morando F, Rosi S, Gola E, Nardi M, Piano S, Fasolato S, Stanco M, Cavallin M, Romano A, Sticca A, Caregaro L, Gatta A, Angeli P.

Liver Int. 2015 May;35(5):1508-15. doi: 10.1111/liv.12583. Epub 2014 May 21.

PMID:
24811138
34.

Assessment of alcohol consumption in liver transplant candidates and recipients: the best combination of the tools available.

Piano S, Marchioro L, Gola E, Rosi S, Morando F, Cavallin M, Sticca A, Fasolato S, Forza G, Chiara Frigo A, Plebani M, Zanus G, Cillo U, Gatta A, Angeli P.

Liver Transpl. 2014 Jul;20(7):815-22. doi: 10.1002/lt.23881. Epub 2014 May 26.

35.

BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.

Damiani D, Tiribelli M, Franzoni A, Michelutti A, Fabbro D, Cavallin M, Toffoletti E, Simeone E, Fanin R, Damante G.

Am J Hematol. 2013 Oct;88(10):848-52. doi: 10.1002/ajh.23516. Epub 2013 Jul 23.

36.

Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites.

Piano S, Rosi S, Maresio G, Fasolato S, Cavallin M, Romano A, Morando F, Gola E, Frigo AC, Gatta A, Angeli P.

J Hepatol. 2013 Sep;59(3):482-9. doi: 10.1016/j.jhep.2013.03.039. Epub 2013 May 7.

PMID:
23665185
37.

How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists.

Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A, Rosi S, Gola E, Frigo AC, Stanco M, Destro C, Rupolo G, Mantoan D, Gatta A, Angeli P.

J Hepatol. 2013 Aug;59(2):257-64. doi: 10.1016/j.jhep.2013.03.010. Epub 2013 Mar 21.

PMID:
23523582
38.

Proactive evaluation of clinical risk: a FMECA analysis in pediatric chemotherapy.

Ciofi degli Atti M, Paolini V, Cavallin M, Corsetti T, Locatelli F, Trucco P, Raponi M.

Ann Ig. 2013 Jan-Feb;25(1):15-21. doi: 10.7416/ai.2013.1902.

PMID:
23435776
39.

A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies.

Cohen RB, Aamdal S, Nyakas M, Cavallin M, Green D, Learoyd M, Smith I, Kurzrock R.

Eur J Cancer. 2013 May;49(7):1521-9. doi: 10.1016/j.ejca.2013.01.013. Epub 2013 Feb 21.

PMID:
23433846
40.

Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery.

Bundred N, Gardovskis J, Jaskiewicz J, Eglitis J, Paramonov V, McCormack P, Swaisland H, Cavallin M, Parry T, Carmichael J, Dixon JM.

Invest New Drugs. 2013 Aug;31(4):949-58. doi: 10.1007/s10637-012-9922-7. Epub 2013 Jan 13.

PMID:
23315029
41.

Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene.

Morando F, Rosi S, Fasolato S, Cavallin M, Gola E, Gatta A, Angeli P.

J Med Virol. 2013 Feb;85(2):210-3. doi: 10.1002/jmv.23448. Epub 2012 Nov 14.

PMID:
23160952
42.

Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.

Damiani D, Tiribelli M, Geromin A, Cerno M, Sperotto A, Toffoletti E, Simeone E, Michelutti A, Cavallin M, Fanin R.

Ann Hematol. 2012 Dec;91(12):1937-43. doi: 10.1007/s00277-012-1551-x. Epub 2012 Aug 15.

PMID:
22893485
43.

Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies.

Galioto A, Morando F, Rosi S, Schipilliti M, Fasolato S, Magrin M, Frigo AC, Adami F, Cavallin M, Zanus G, Plebani M, Romano A, Sticca A, Cillo U, Gatta A, Angeli P.

Transpl Int. 2012 Jan;25(1):25-33. doi: 10.1111/j.1432-2277.2011.01362.x. Epub 2011 Oct 15.

44.

Hepatorenal syndrome.

Angeli P, Morando F, Cavallin M, Piano S.

Contrib Nephrol. 2011;174:46-55. doi: 10.1159/000329235. Epub 2011 Sep 9. Review.

PMID:
21921608
45.

The liver: another organ involved in Muir Torre syndrome?

Morando F, Alaibac M, Romano A, Cavallin M, Piano S, Pizzi M, Mescoli C, Pilati P, Gatta A, Angeli P.

Fam Cancer. 2012 Mar;11(1):7-12. doi: 10.1007/s10689-011-9450-1.

PMID:
21614588
46.

Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.

Tiribelli M, Geromin A, Michelutti A, Cavallin M, Pianta A, Fabbro D, Russo D, Damante G, Fanin R, Damiani D.

Cancer. 2011 May 15;117(10):2156-62. doi: 10.1002/cncr.25753. Epub 2010 Nov 29.

47.

Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?

Piano S, Morando F, Fasolato S, Cavallin M, Boscato N, Boccagni P, Zanus G, Cillo U, Gatta A, Angeli P.

J Hepatol. 2011 Aug;55(2):491-6. doi: 10.1016/j.jhep.2011.02.002. Epub 2011 Feb 18.

48.

The Olfactory Bulb: A Metabolic Sensor of Brain Insulin and Glucose Concentrations via a Voltage-Gated Potassium Channel.

Tucker K, Cavallin MA, Jean-Baptiste P, Biju KC, Overton JM, Pedarzani P, Fadool DA.

Results Probl Cell Differ. 2010;52:147-57. doi: 10.1007/978-3-642-14426-4_12. Review.

49.

State-dependent sculpting of olfactory sensory neurons is attributed to sensory enrichment, odor deprivation, and aging.

Cavallin MA, Powell K, Biju KC, Fadool DA.

Neurosci Lett. 2010 Oct 11;483(2):90-5. doi: 10.1016/j.neulet.2010.07.059. Epub 2010 Aug 5.

50.

Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.

Damiani D, Tiribelli M, Michelutti A, Geromin A, Cavallin M, Fabbro D, Pianta A, Malagola M, Damante G, Russo D, Fanin R.

Leuk Res. 2010 Jul;34(7):942-5. doi: 10.1016/j.leukres.2010.01.008. Epub 2010 Jan 31.

PMID:
20122734

Supplemental Content

Loading ...
Support Center